Pharmacokinetic and Pharmacodynamic Studies of Efficacy, Tolerability and Safety of Higher Dosage Rifapentine for Treatment of Tuberculosis.
Phase of Trial: Phase II
Latest Information Update: 16 Aug 2012
At a glance
- Drugs Rifapentine (Primary) ; Rifampicin
- Indications Tuberculosis
- Focus Biomarker; Pharmacogenomic; Pharmacokinetics
- 16 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 16 Jul 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 16 Jan 2010 New trial record